Innoviva Stock Income Statements

Innoviva Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Innoviva Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-06-30	2018-03-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-09-30	2008-06-30	2008-03-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30

revenue:
royalty revenue, net of amortization of capitalized fees paid of 3,456 in the three months ended june 30, 2025 and 2024, and 6,912 in the six months ended june 30, 2025 and 2024	63,880,000
net product sales	35,493,000	30,279,000	28,935,000	27,822,000	21,651,000	19,084,000	19,675,000	13,701,000	15,727,000	11,514,000	14,587,000	5,107,000
license and other revenue	910,000	546,000
total revenue	100,283,000	88,632,000	91,806,000	89,508,000	99,898,000	77,499,000	85,840,000	67,259,000	80,992,000	76,372,000	65,803,000	67,257,000
yoy	0.39%	14.37%	6.95%	33.08%	23.34%	1.48%	30.45%	0.00%
qoq	13.15%	-3.46%	2.57%	-10.40%	28.90%	-9.72%	27.63%	-16.96%	6.05%	16.06%	-2.16%
cost of products sold	10,590,000	8,842,000	7,165,000	9,990,000	8,472,000	10,971,000	13,130,000	10,182,000	8,979,000	8,749,000	10,113,000	3,680,000
amortization of acquired intangible assets	6,547,000	6,475,000	6,511,000	6,511,000	6,440,000	6,440,000	6,510,000	6,511,000	4,958,000	3,805,000	4,070,000	1,511,000
gross profit	83,146,000	73,315,000
yoy
qoq	13.41%
gross margin %	82.91%	82.72%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
operating expenses:
selling, general and administrative	26,412,000	27,491,000	31,326,000	26,219,000	27,740,000	30,405,000	26,319,000	28,636,000	23,542,000	19,735,000	17,454,000	27,810,000																													22,834,000	12,282,000
research and development	7,983,000	4,396,000	3,665,000	3,551,000	2,560,000	3,878,000	2,356,000	3,989,000	14,989,000	12,588,000	9,985,000	11,725,000	13,884,000	5,838,000	40,000	449,000	38,000	49,000	219,000	1,010,000										311,000	348,000	354,000	286,000	370,000	392,000	547,000	638,000	712,000	1,909,000	2,125,000	43,387,000	33,395,000	31,739,000	26,416,000	27,026,000	29,549,000	33,202,000	27,837,000	22,798,000	20,464,000	18,537,000	18,705,000	20,351,000	19,541,000	20,020,000	19,557,000	20,075,000	19,996,000	26,779,000	31,964,000	43,497,000	48,858,000	38,002,000	39,103,000	40,751,000	48,708,000	41,023,000	36,249,000	28,050,000	29,355,000
total operating expenses	34,395,000	31,887,000											25,666,000	12,330,000	3,153,000	3,309,000	4,266,000	6,035,000	5,689,000	4,264,000	3,155,000	2,563,000	2,332,000	4,962,000	4,347,000	3,015,000	4,019,000	4,411,000	11,685,000	8,621,000	10,732,000	11,149,000	5,391,000	6,595,000	6,644,000	5,128,000	5,547,000	6,151,000	10,541,000	10,728,000		45,677,000	43,113,000	34,731,000	34,780,000	37,139,000	41,059,000	35,633,000	30,046,000	27,633,000	25,147,000	25,696,000	26,827,000	26,596,000	26,846,000	27,892,000	26,619,000	32,315,000	35,945,000	40,426,000	53,009,000	57,656,000	46,154,000	46,971,000	49,650,000	55,982,000	47,290,000	42,383,000	36,104,000	35,833,000
income from operations	48,751,000	41,428,000											82,554,000	77,729,000	104,527,000	94,553,000	96,540,000	79,483,000	84,787,000	84,430,000	75,791,000	76,115,000	73,639,000	60,793,000	59,760,000	52,168,000	57,661,000	62,675,000	40,695,000	40,022,000	47,830,000	29,343,000	27,918,000	25,877,000	17,532,000	8,434,000	5,108,000	745,000									86,040,000
yoy													-14.49%	-2.21%	23.28%	11.99%	27.38%	4.42%	15.14%	38.88%	26.83%	45.90%	27.71%	-3.00%	46.85%	30.35%	20.55%	113.59%	45.77%	54.66%	172.82%	247.91%	446.55%	3373.42%
qoq	17.68%												6.21%	-25.64%	10.55%	-2.06%	21.46%	-6.26%	0.42%	11.40%	-0.43%	3.36%	21.13%	1.73%	14.55%	-9.53%	-8.00%	54.01%	1.68%	-16.32%	63.00%	5.10%	7.89%	47.60%	107.87%	65.11%	585.64%
operating margin %	48.61%	46.74%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
changes in fair values of equity method investments	13,082,000	-13,549,000	21,256,000	18,231,000	60,108,000	-35,342,000	-9,506,000	-71,980,000	19,911,000	-15,817,000
changes in fair values of equity and long-term investments	11,280,000	-65,299,000	15,206,750	16,936,000	30,556,000	13,335,000					16,970,250	-130,000	-58,600,000	-9,411,000	-42,943,000	33,613,000
interest and dividend income	4,925,000	4,538,000	-5,768,000	-5,500,000	-3,474,000	-4,399,000	-4,786,000	-4,114,000	-3,553,000	-3,365,000	-3,188,000	-2,135,000	724,000	322,000
interest expense	-4,663,000	-4,711,000	4,749,000	5,807,000	5,802,000	5,851,000	5,952,000	4,396,000	4,382,000	4,427,000	4,028,000	5,096,000	-3,655,000	-3,010,000	-4,841,000	-4,790,000	-4,745,000	-4,694,000	-4,651,000	-4,603,000	-4,561,000	-4,516,000	-4,689,000	-4,693,000	-4,661,000
other income	-777,000	-996,000	-126,000	914,000	973,000	1,236,000	680,000	1,047,000	1,896,000	1,346,000	2,623,000	-28,000	-528,000	-250,000	-1,590,000	-652,000					30,000	68,000	-223,000	-115,000	-8,000	1,000		39,000				47,000	56,000	1,719,000				1,178,000	255,000	83,000			8,192,000
income before income taxes	72,598,000	-38,589,000	24,694,000	6,849,000	-39,279,000	45,124,000	61,201,000	85,952,000	5,805,000	41,140,000	-64,688,000	286,424,000	20,495,000	44,718,000	56,489,000	123,177,000										48,527,000
income tax benefit (expense)	-8,910,000
net income attributable to innoviva stockholders	63,688,000	-46,584,000	20,332,000	1,213,000	-34,685,000	36,532,000	61,531,000	82,046,000	1,280,000	34,865,000	-68,314,000	265,523,000	939,000	15,773,000	10,345,000	72,438,000	88,948,000	94,123,000	53,903,000	28,218,000	76,844,000	65,437,000	45,949,000	39,809,000	37,740,000	33,790,000	47,089,000	54,626,000	29,581,000
yoy	-283.62%	-227.52%	-66.96%	-98.52%	-2809.77%	4.78%	-190.07%	-69.10%	36.32%	121.04%	-760.36%	266.55%	-98.94%	-83.24%	-80.81%	156.71%	15.75%	43.84%	17.31%	-29.12%	103.61%	93.66%	-2.42%	-27.12%	27.58%
qoq	-236.72%	-329.12%	1576.17%	-103.50%	-194.94%	-40.63%	-25.00%	6309.84%	-96.33%	-151.04%	-125.73%	28177.21%	-94.05%	52.47%	-85.72%	-18.56%	-5.50%	74.62%	91.02%	-63.28%	17.43%	42.41%	15.42%	5.48%	11.69%	-28.24%	-13.80%	84.67%
net income margin %	63.51%	-52.56%	22.15%	1.36%	-34.72%	47.14%	71.68%	121.99%	1.58%	45.65%	-103.82%	394.79%
net income per share																																																																							-0.678	-0.49
basic	1.01	-0.74	0.013	0.02	-0.55	0.58																																						-0.39			1.01
diluted	0.77	-0.74	0.013	0.02	-0.55	0.46																																						-0.39			0.93
shares used to compute net income per share:
basic	62,865	62,709	15,689.75	62,569	62,526	63,185
diluted	84,452	62,709	15,755	62,951	62,526	84,531
royalty revenue, net of amortization of capitalized fees paid of 3,456 in the three months ended march 31, 2025 and 2024		57,807,000
income tax expense		-7,995,000	4,362,000	5,636,000		8,592,000	-330,000	3,906,000		6,275,000	3,626,000	57,077,000		6,860,000	10,839,000	20,531,000										8,508,000														-278,000
royalty revenue, net of amortization of capitalized fees paid of 3,456 in the three months ended september 30, 2024 and 2023, and 10,368 in the nine months ended september 30, 2024 and 2023			44,803,250	57,056,000
license revenue			4,783,750	4,630,000	14,505,000				3,000,000	8,000,000
expenses:
cost of license revenue										1,600,000
total expenses			67,112,000	82,659,000	139,177,000	32,375,000	24,639,000	-18,693,000	75,187,000	35,232,000	130,491,000	-219,167,000
royalty revenue, net of amortization of capitalized fees paid of 3,456 in the three months ended june 30, 2024 and 2023, and 6,912 in the six months ended june 30, 2024 and 2023					63,742,000
income tax benefit					-4,594,000				4,525,000				-876,000
royalty revenue, net of amortization of capitalized fees paid of 3,456 in the three months ended march 31, 2024 and 2023						58,415,000
royalty revenue, net of amortization of capitalized fees paid of 3,456 in the three months ended september 30, 2023 and 2022, and 10,368 in the nine months ended september 30, 2023 and 2022							43,170,250	53,558,000
gain on sale of theravance respiratory company, llc												-266,696,000
loss on debt extinguishment											5,165,500			-20,662,000
changes in fair values of other equity and long-term investments							1,221,750	2,640,000	83,000	2,164,000
net income							61,531,000	82,046,000	1,280,000	34,865,000	-68,314,000	229,347,000	21,371,000	37,858,000	45,650,000	102,646,000										40,019,000	50,167,000	56,616,000	30,330,000	23,767,000	35,146,000	16,845,000	15,033,000	14,597,000	4,435,000	-4,584,000	-7,810,000	-10,667,000	-21,271,000	-63,564,000	-67,703,000	-46,985,000	-36,429,000	-37,360,000	-34,692,000	-37,120,000	84,594,000	-30,626,000	-25,045,000	-22,667,000	-21,222,000	-20,806,000	-22,536,000	-22,183,000	-21,692,000	-19,217,000	-20,928,000	-27,026,000	-29,764,000	-32,364,000	-45,125,000	-49,450,000	-37,837,000	-37,780,000	-41,475,000	-48,952,000		-37,786,000	-31,716,000	-31,451,000	-29,171,000	-22,287,000
net income attributable to noncontrolling interests												-36,176,000
basic net income per share attributable to innoviva stockholders							0.96	1.26	0.02	0.51	-0.98	3.81	0.01	0.23	0.28	1.04	1.01	0.93	0.53	0.28	0.76	0.65	0.45	0.39	0.37	0.33	0.47	0.54	0.29
diluted net income per share attributable to innoviva stockholders							0.75	0.98	0.02	0.42	-0.7	2.8	0.05	0.2	0.24	0.9	0.9	0.84	0.49	0.26	0.69	0.59	0.42	0.36	0.34	0.31	0.43	0.49	0.27
shares used to compute innoviva basic and diluted net income per share:
shares used to compute basic net income per share							-581	64,953	65,341	67,786	4	69,731	69,643	69,544	-4,236	69,458										101,059	100,936	100,873	100,604	106,841	107,614	107,487	109,282	111,359	112,482
shares used to compute diluted net income per share							-628	86,164	65,489	89,788	176	95,830	95,653	93,730	-4,226	81,699										113,376	113,363	113,399	113,566	119,796	120,463	120,336	121,993	124,316	113,178
royalty revenue, net of amortization of capitalized fees paid of 3,456 in the three months ended june 30, 2023 and 2022, and 6,912 in the six months ended june 30, 2023 and 2022									62,265,000
royalty revenue, net of amortization of capitalized fees paid of 3,456 in the three months ended march 31, 2023 and 2022										56,858,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended september 30, 2022 and 2021, and 10,368 in the nine months ended september 30, 2022 and 2021											65,107,250	62,150,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended june 30, 2022 and 2021, and 6,912 in the six months ended june 30, 2022 and 2021													108,220,000
general and administrative													11,782,000	6,492,000	3,113,000	2,860,000	4,228,000	5,986,000	5,470,000	3,254,000	2,596,000	2,563,000	2,332,000	4,962,000	4,347,000	3,015,000	4,019,000	4,411,000	8,985,000	8,310,000	10,384,000	10,795,000	5,105,000	6,225,000	6,252,000	4,581,000	4,909,000	5,439,000	8,632,000	8,603,000			11,374,000	8,315,000	7,754,000	7,590,000	7,857,000	7,796,000	7,248,000	7,169,000	6,610,000	6,991,000	6,476,000	7,061,000	6,796,000	7,052,000	6,494,000	7,256,000	9,166,000	8,462,000	9,512,000	8,798,000	8,152,000	7,868,000	8,899,000	7,274,000	4,578,000	5,042,000	6,620,000	5,070,000
net income attributable to noncontrolling interest													20,432,000	22,085,000	35,305,000	30,208,000										6,229,000	3,078,000	1,990,000	749,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended march 31, 2022 and 2021														90,059,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended september 30, 2021 and 2020, and 10,368 in the nine months ended september 30, 2021 and 2020															71,046,500	97,862,000
revenue from collaborative arrangements with a related party
total net revenue															107,680,000	97,862,000											61,680,000	67,086,000	52,380,000	48,643,000	58,562,000	40,492,000	33,309,000	32,472,000	24,176,000	13,562,000	10,655,000	6,896,000	999,000	934,000	165,000
interest income															125,750	453,000	20,000	30,000	23,000	41,000	158,000	1,302,000	1,538,000	1,624,000	1,403,000	975,000	370,000	380,000	391,000	376,000	306,000	236,000	162,000	157,000	92,000	90,000	85,000	116,000	93,000	165,000	188,000	192,000	189,000		158,000	90,000	56,000	81,000	118,000	145,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended june 30, 2021 and 2020, and 6,912 in the six months ended june 30, 2021 and 2020																	100,806,000

royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in three months ended march 31, 2021 and 2020																		85,518,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended september 30, 2020 and 2019, and 10,368 in the nine months ended september 30, 2020 and 2019																			59,079,500	88,694,000
changes in fair values of equity investments
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended june 30, 2020 and 2019, and 6,912 in the six months ended june 30, 2020 and 2019																					68,946,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended march 31, 2020 and 2019																						78,678,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended september 30, 2019 and 2018, and 10,368 in the nine months ended september 30, 2019 and 2018																							46,261,250	65,755,000
general and administrative - related party																													2,700,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended june 30, 2019 and 2018, and 6,912 in the six months ended june 30, 2019 and 2018																									64,107,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended march 31, 2019 and 2018																										55,183,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended september 30, 2018 and 2017 and 10,368 in the nine months ended september 30, 2018 and 2017																											61,680,000
revenue from collaborative arrangements from a related party																														221,000	221,000	221,000	221,000	221,000	221,000	221,000	221,000	222,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended june 30, 2018 and 2017 and 6,912 in the six months ended june 30, 2018 and 2017																												67,086,000
royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of 3,456 in the three months ended march 31, 2018 and 2017																													52,380,000
royalty revenue from a related party, net of amortization for capitalized fees paid to a related party of 3,456 for the three months ended september 30, 2017 and 2016 and 10,368 for the nine months ended september 30, 2017 and 2016																														48,422,000
basic net income per share																														0.22	0.33	0.16										-0.44	-0.37		-0.37	-0.42
diluted net income per share																														0.21	0.3	0.15										-0.44	-0.37		-0.37	-0.42
shares used to compute basic and diluted net income per share:
royalty revenue from a related party, net of amortization for capitalized fees paid to a related party of 3,456 for the three months ended june 30, 2017 and 2016 and 6,912 for the six months ended june 30, 2017 and 2016																															58,341,000
royalty revenue from a related party, net of amortization for capitalized fees paid to a related party of 3,456 for the three months ended march 31, 2017 and 2016																																40,271,000
royalty revenue from a related party, net of amortization for capitalized fees paid to a related party of 3,456 and 3,455 for the three months ended september 30, 2016 and 2015 and 10,368 and 10,367 for the nine months ended september 30, 2016 and 2015																																	33,088,000
basic net income per share:																																	0.14
diluted net income per share:																																	0.13
cash dividends declared per common share																																						0.25	0.25
royalty revenue from a related party, net of amortization for capitalized fees paid to a related party of 3,456 and 3,456 for the three months ended june 30, 2016 and 2015 and 6,912 and 6,912 for the six months ended june 30, 2016 and 2015																																		32,251,000
basic and diluted net income per share																																		0.13	0.04	-0.04	-0.07		-0.19	-0.57	-0.62							-0.37	-0.31	-0.28	-0.29	-0.28	-0.35	-0.35	-0.35	-0.31
cash dividend declared per common share																																				0.25	0.25
royalty revenue from a related party, net of amortization for capitalized fees paid to a related party of 3,456 for the three months ended march 31, 2016 and 2015																																			23,955,000
royalty revenue from a related party, net of amortization for capitalized fees paid to a related party of 3,455 and 3,233 for the three months ended september 30, 2015 and 2014 and 10,367 and 7,611 for the nine months ended september 30, 2015 and 2014																																				13,341,000
income from continuing operations before income taxes
income from continuing operations, net of tax
income from discontinued operations
basic and diluted net income per share:
continuing operations, net of tax																																				-0.04	-0.07		-0.19	-0.18
discontinued operations
shares used to compute basic and diluted net income per share																																				115,787	115,329	114,658	113,100	110,974
royalty revenue from a related party, net of amortization for capitalized fees paid to a related party of 3,456 and 2,598 for the three months ended june 30, 2015 and 2014 and 6,912 and 4,378 for the six months ended june 30, 2015 and 2014																																					10,434,000
royalty revenue from a related party, net of amortization for capitalized fees paid to a related party of 3,456 and 1,780 for the three months ended march 31, 2015 and 2014																																						6,674,000
income from continuing operations
continuing operations																																						-0.09
royalty revenue from a related party, net of intangible assets amortization: three months—2014-3,233; 2013-0; nine months—2014-7,611; 2013-0																																							729,000
net revenue from collaborative arrangements from a related party																																							270,000	271,000
income tax																																							278,000
royalty revenue from a related party, net of intangible assets amortization: three months—2014-2,598; 2013-0; six months—2014-4,378; 2013-0																																								663,000
product sales																																									945,000
royalty revenue from a related party, net of intangible assets amortization of 1,780 and 0 for the three months ended march 31, 2014 and 2013
net revenue from collaborative arrangements																																									270,000
costs and expenses:
cost of goods sold																																									188,000
total costs and expenses																																									66,409,000
shares used to compute basic and diluted net income share																																									109,859
revenue from collaborative arrangements																																										439,000	1,327,000	1,344,000
net income per share																																																																							-0.678	-0.49
shares used to compute basic earnings per share																																										106,925	97,603		95,027	89,169
shares used to compute diluted earnings per share																																										106,925	97,603		95,027	89,169
interest and other income																																																			136,000	134,000	94,000	413,000	1,172,000	647,000	1,209,000	1,295,000	1,672,000	2,438,000	2,692,000	2,929,000	3,415,000	3,875,000	3,474,000	2,885,000	1,816,000	1,716,000	1,619,000	1,818,000	1,802,000	1,243,000
weighted-average number of shares used in per share calculations:
basic																																												96,379			83,590
diluted																																												96,379			92,080
revenue																																													1,430,000	1,430,000	127,099,000	6,431,000	6,389,000	6,331,000	5,302,000	6,264,000	5,714,000	5,515,000	5,493,000	9,544,000	5,999,000	5,505,000	5,645,000	5,669,000	5,305,000	5,398,000	3,664,250	5,524,000	4,837,000	4,296,000
shares used in computing basic and diluted net income per share																																																82,490	81,811	80,854			64,921	63,236
restructuring charges																																																							30,000	1,283,000	50,000	5,063,000
shares used in computing net income per share																																																			73,726	73,282			62,842	62,288															6,774.25	45,123
basic and diluted net income per common share																																																									-340	-440	-490	-530	-750	-820	-630	-630	-700	-860	-790	-710	-600	-590
shares used in computing net income per common share																																																									61,545,000	61,192,000	61,003,000	60,664,000	60,341,000	60,061,000	311,000	59,762,000	59,440,000	56,871,000	115,000	53,416,000	53,163,000	52,888,000
revenue from related party																																																																			2,169,000	3,006,000	2,913,000	2,757,000	2,740,000	2,637,000
stock-based compensation*																																																																			1,689,000	1,092,000	1,434,000	1,408,000

We provide you with 20 years income statements for Innoviva stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Innoviva stock. Explore the full financial landscape of Innoviva stock with our expertly curated income statements.

The information provided in this report about Innoviva stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.